Last reviewed · How we verify
Atrial Fibrillation or Flutter with a High Risk of Stroke and at Least One Risk Factor for Stroke — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| No OAC | no-oac | Pfizer | Direct Oral Anticoagulant | Factor Xa |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 1 drug in Atrial Fibrillation or Flutter with a High Risk of Stroke and at Least One Risk Factor for Stroke
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Atrial Fibrillation or Flutter with a High Risk of Stroke and at Least One Risk Factor for Stroke:
- Atrial Fibrillation or Flutter with a High Risk of Stroke and at Least One Risk Factor for Stroke treatment updates — RSS
- Atrial Fibrillation or Flutter with a High Risk of Stroke and at Least One Risk Factor for Stroke treatment updates — Atom
- Atrial Fibrillation or Flutter with a High Risk of Stroke and at Least One Risk Factor for Stroke treatment updates — JSON
Cite this brief
Drug Landscape (2026). Atrial Fibrillation or Flutter with a High Risk of Stroke and at Least One Risk Factor for Stroke — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/atrial-fibrillation-or-flutter-with-a-high-risk-of-stroke-and-at-least-one-risk-factor-for-stroke. Accessed 2026-06-10.
Related
- Atrial Fibrillation or Flutter with a High Risk of Stroke and at Least One Risk Factor for Stroke full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing